Doxorubicin Injection

16 June 2009

Products Affected - Description

Doxorubicin, lyophilized powder, Baxter
10 mg vial, single package (NDC 10019-0920-01) - discontinued
50 mg vial, single package (NDC 10019-0921-02) - discontinued

Reason for the Shortage

• Baxter has discontinued their doxorubicin lyophilized powder products; the company would not provide a reason for the discontinuation.
• Bedford is the sole supplier of doxorubicin lyophilized powder and states the shortage was due to increased demand for product.

Estimated Resupply Dates

• Bedford has available doxorubicin lyophilized powder in Novaplus 10 mg vials (NDC 55390-0241-10) and Novaplus 50 mg vials (NDC 55390-0243-01). Adriamycin lyophilized powder in 10 mg vials (NDC 55390-0231-01), 20 mg vials (NDC 55390-0232-10), and 50 mg vials (NDC 55390-0233-01) are available.
• Bedford has doxorubicin solution for injection available in Novaplus 5 mL vials (NDC 55390-0245-10), Novaplus 10 mL vials (NDC 55390-0246-10), Novaplus 25 mL vials (NDC 55390-0247-01), and Novaplus 100 mL multi-dose vials (NDC 55390-0248-01). Adriamycin solution for injection in 5 mL vials (NDC 55390-0235-10), 10 mL vials (NDC 55390-0236-10), 25 mL vials (NDC 55390-0237-01), and 100 mL multi-dose vials (NDC 55390-0238-01) is also available.
• APP has doxorubicin solution for injection available in all presentations including a 5 mL vial (NDC 63323-0883-05), 10 mL vial (NDC 63323-0883-10), 25 mL vial (NDC 63323-0883-30), and 100 mL multi-dose vial (NDC 63323-0101-61).
• Teva has doxorubicin solution for injection available in a 5 mL vial (NDC 00703-5043-03), 25 mL vial (NDC 00703-5046-01), and 100 mL vial (NDC 00703-5040-01).

Related Shortages

• Bleomycin Injection
• Carmustine Injection— Resolved
• Cisplatin Injection— Resolved
• Cyclophosphamide for Injection— Resolved
• Cyclophosphamide Tablets— Resolved
• Cytarabine Injection
• Epirubicin Injection— Resolved
• Fluorouracil Injection— Resolved
• Hydroxyurea Capsules— Resolved
• Ifosfamide— Resolved
• Interferon Alfa Injection— No Longer Available
• Leuprolide Implant— No Longer Available
• Mechlorethamine Hydrochloride Injection— Resolved
• Melphalan Injection Injection— Resolved
• Methotrexate Injection
• Mitomycin Injection
• Paclitaxel Injection— Resolved
• Procarbazine Capsules— Resolved
• Thiotepa Injection
• Vinblastine Injection
• Vincristine Injection— Resolved

Updated

June 16, 2009; May 6, 2009; April 13, 2009; March 23, 2009; February 25, 2009; February 23, 2009; January 23, 2009; January 22, 2009; December 17, 2008; December 1, 2008; November 5, 2008; November 3, 2008; October 6, 2008; September 2, 2008, University of Utah, Drug Information Service. Copyright 2009, University of Utah, Drug Information Service.

Back to Drug Shortage Product Bulletins